Moreover, such markers that allow to a less invasive way for the diagnosis, prognosis and treatment monitoring of chronic prostatitis is required for improving patient care, increase the specificity of the PSA test for prostate cancer detection and lead to an improvement of prostate cancer management. This evidence concerns the gene PROS1 and prostatitis.